Psychostimulants may have role for cancer-related fatigue
AssetsmethylphenidatedexmethylphenidateDiseasescancer-related fatigue
Signals
Every pharma-relevant, de-duplicated event surfaced so far, primary source first. Client-scoped signals are never shown here.
‘Fixable’ barriers limit use of integrative oncology strategies
Medicare Part D denials may limit appropriate cancer drug access
Diseasescancerhematologic malignanciesprostate cancerbreast cancer
Metric has ‘pretty profound’ link to prostate cancer outcomes
CompaniesAstellas PharmaAstraZenecaBayerEli Lilly & Co.Johnson & Johnson Innovative MedicineMerckNovartisPfizerSanofiSumitomo Pharma America Inc.Diseasesmetastatic castration-sensitive prostate cancer
Smoking cessation program could avert thousands of cancer deaths
Metabolic improvements cut MASLD-linked colorectal neoplasia risk
Diseasesmetabolic dysfunction-associated steatotic liver diseasecolorectal neoplasia
Double lung transplant may benefit some with stage IV NSCLC
CompaniesNorthwestern UniversityAbbVieAstraZenecaBiodesixBoehringer IngelheimBristol Myers SquibbEisaiEli Lilly & Co.Foundation MedicineFreenomeGeneCkerGenentech/RocheGuardant HealthImagine AIImmuneOnciaJazz PharmaceuticalsLunitMerckNeoGenomicsNeoImmunTechNovocurePicture HealthPredicineOncoHostRegeneronTakedaTempusDiseasesstage IV non-small cell lung cancerrespiratory failure
Healio AI, Healio LIVE expand access to CME in new partnership
CompaniesHealioHealio LIVE
Novel ovarian cancer prevention surgery benefits sexual function
CompaniesMoffitt Cancer CenterDiseasesovarian cancer
EHR nudges can improve guideline-concordant cancer care
CompaniesUniversity of Pennsylvania Perelman School of MedicineDiseasesnon-small cell lung cancer
Reproductive treatments may have ‘small’ link to hormonal cancers
Diseasesbreast cancerovarian cancerpancreatic cancerthyroid canceruterine cancermelanoma
Focused ultrasound may improve pancreatic cancer outcomes
CompaniesSeoul National University College of MedicineSeoul National University HospitalCity of HopeAssetsFOLFIRINOXDiseasespancreatic cancerborderline resectable pancreatic cancerlocally advanced pancreatic cancer
Surgery alone may be adequate in intermediate-risk thyroid cancer
Diseasesintermediate-risk papillary thyroid carcinoma
Virtual smoking cessation program benefits patients with cancer
CompaniesMassachusetts General BrighamMemorial Sloan Kettering Cancer CenterDiseasescancer
Drug costs for federally sponsored trials are substantial
Barriers stopping US biotechs from running FIH trials on home soil
ICH GCP Annex 2 will strengthen sponsor confidence in the use of DCTs and RWD
FDA approves ArkBio’s ziresovir for Phase II trial in severe RSV
CompaniesArkBioAssetsziresovirAK0529Diseasesrespiratory syncytial virus
Fate Therapeutics begins Phase II trial of FT819 for lupus nephritis
CompaniesFate TherapeuticsAssetsFT819Diseaseslupus nephritissystemic lupus erythematosus (SLE)
AstraZeneca touts Enhertu, Orpathys dual lung cancer wins amid bispecific failure
CompaniesAstraZenecaMSDAssetsvolrustomigKeytrudaEnhertuTagrissoOrpathysDiseasesnon-small cell lung cancerHER2-mutant non-squamous NSCLCEGFRm NSCLC